Finance

Lists
1734:TPE
Sinphar Pharmaceutical Co Ltd
NT$32,10
0,00%
(0,00) 1D
2 Okt., 13:30:20 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1734...
Open
NT$31,80
High
NT$32,20
Low
NT$31,80
Mkt. cap
6,47 mjd
Avg. vol.
212,49 k
Volume
158,01 k
Dividend
2,94%
Quarterly dividend
NT$0,24
Ex-dividend date
24 Jul. 2026
P/E ratio
18,43
52-wk high
NT$32,80
52-wk low
NT$28,11
EPS
NT$1,74
Shares outstanding
167,72 m
No. of employees
984
Open
NT$31,80
High
NT$32,20
Low
NT$31,80
Mkt. cap
6,47 mjd
Avg. vol.
212,49 k
Volume
158,01 k
Dividend
2,94%
Quarterly dividend
NT$0,24
Ex-dividend date
24 Jul. 2026
P/E ratio
18,43
52-wk high
NT$32,80
52-wk low
NT$28,11
EPS
NT$1,74
Shares outstanding
167,72 m
No. of employees
984
News stories
From web sources and news partners
About Sinphar Pharmaceutical Co Ltd
CEO-
Employees984
Founded1977
HeadquartersDongshan Township, Yilan County, Taiwan
SectorPharmaceutical industry
Websitesinphar.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
872,73 m
880,02 m
826,63 m
871,15 m
Cost of goods sold
490,24 m
495,03 m
464,18 m
462,81 m
Cost of revenue
490,24 m
495,03 m
464,18 m
462,81 m
Research and development expenses
40,00 m
37,51 m
40,54 m
33,63 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
233,62 m
248,91 m
230,57 m
262,94 m
Operating expense
273,62 m
286,42 m
271,17 m
296,61 m
Total operating expenses
763,86 m
781,45 m
735,35 m
759,41 m
Operating income
108,87 m
98,57 m
91,28 m
111,74 m
Other non operating income
553,00 k
13,89 m
1,91 m
-5,70 m
EBT including unusual items
105,00 m
105,85 m
88,53 m
106,97 m
EBT excluding unusual items
105,69 m
105,82 m
88,52 m
107,06 m
Income tax expense
24,32 m
6,94 m
20,28 m
16,49 m
Effective tax rate
23,16%
6,56%
22,91%
15,42%
Other operating expenses
-
-
-
-
Net income
83,35 m
101,95 m
73,80 m
92,57 m
Net profit margin
9,55%
11,59%
8,93%
10,63%
Earnings per share
-
-
-
-
Interest and investment income
2,38 m
3,44 m
3,74 m
3,50 m
Interest expense
-8,31 m
-7,80 m
-7,21 m
-6,00 k
Net interest expenses
-5,93 m
-4,35 m
-3,47 m
3,49 m
Depreciation and amortization charges
-
-
-
-
EBITDA
168,79 m
159,15 m
152,37 m
173,65 m
Gain or loss from assets sale
710,00 k
5,00 k
-4,00 k
129,00 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme